Related Experiment Videos
Lipoxin biosynthesis in inflammatory bowel disease.
Martin J Mangino1, Lionel Brounts, Bruce Harms
1Department of Surgery, University of Wisconsin Medical School, 600 Highland Avenue, Madison, WI 53792, USA. mjmangino@vcu.edu
Prostaglandins & Other Lipid Mediators
|March 7, 2006
Summary
Patients with ulcerative colitis (UC) show defective lipoxin biosynthesis in the colon, potentially explaining their persistent inflammation. Aspirin can still trigger lipoxin synthesis in UC tissues.
Area of Science:
- Gastroenterology
- Immunology
- Biochemistry
Background:
- Lipoxins are crucial anti-inflammatory lipid mediators produced in the gut.
- They play a key role in limiting and resolving inflammation.
- Persistent inflammation in ulcerative colitis (UC) suggests a potential defect in these resolution pathways.
Purpose of the Study:
- To investigate colonic lipoxin biosynthesis in patients with UC.
- To determine if impaired lipoxin production contributes to persistent inflammation in UC.
Main Methods:
- Colonic mucosa from UC patients and organ donors was cultured.
- Lipoxin A4 (LXA) and 15-epi-LXA4 (ATL) levels were measured using ELISA.
- 15-lipoxygenase protein expression was assessed via Western blot.
Main Results:
- UC colonic mucosa produced significantly lower levels of LXA (12-fold) compared to controls.
- UC tissues synthesized ATL in response to aspirin, indicating preserved pathway capacity.
- 15-lipoxygenase-2, crucial for lipoxin synthesis, was significantly lower in UC patients.
- Inhibiting 15-lipoxygenase worsened experimental colitis in mice.
Conclusions:
- Ulcerative colitis patients exhibit defective colonic lipoxin biosynthesis.
- This defect may impair the resolution of inflammation in UC.
- Targeting lipoxin pathways could offer new therapeutic strategies for UC.